2026/9/11
Presentation at Obesity Science & Innovation USA 2026
Ajinomoto Bio-Pharma Services will be attending and presenting a poster at Obesity Science & Innovation USA 2026 on September 23-24, 2026.
Obesity Science & Innovation USA 2026 will cover everything from innovation to impact, where attendees discuss how obesity therapeutics are transforming lives and reshaping global wellness.
We will present our innovative proprietary platform technologies AJIPHASE® and CORYNEX® and explain how it can be used to effectively manufacture peptides.
We look forward to your visit.
| Event Name | Obesity Science & Innovation USA 2026 |
|---|---|
| Dates | September 23(Wed) – 24 (Thu), 2026 |
| Venue | Hynes Convention Center |
| Exhibition | Poster |
Poster presentation
| Topics and Presenters | “Scalable and sustainable peptide manufacturing using Ajiphase and Corynex” Yohei Yamada |
|---|---|
| Executive Summary | Ajiphase is Ajinomoto’s innovative liquid phase synthesis platform to manufacture peptides and oligonucleotides. It is an eco-friendly method that enables mass production with high purity, and seamless scale up from lab to commercial. Corynex is our proprietary microbial secretion platform based on C. glutamicum that enables high-titer and high-purity production of various peptides, VHHs, and conjugates. It is very scalable, sustainable, non-endotoxic, and doesn’t require refolding. |
| Date, Time and Venue | September 23(Wed) – 24 (Thu), 2026 |